Zhongzhi Pharmaceutical H1 revenue falls 10%
China’s Zhongzhi Pharmaceutical says H1 revenue fell 10%, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.